Vasorin is a Type I membrane protein, which is predominantly expressed in vascular smooth muscle cells in a developmentally regulated pattern. The expression level of Vasorin can be down regulated during vessel repair after arterial injury. Vasorin binds to transforming growth factor beta (TGF-Î?) and attenuates TGF-Î? signaling in vitro. Vasorin is a potential therapeutic […]
| Inventor | Institute |
|---|---|
| Ayham Alnabulsi | Vertebrate Antibodies Limited |
| Cat. #: | 153470 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Cell signaling and signal transduction |
| Application: | WB ; ELISA ; IHC |
| Target: | Vasorin |
| Reactivity: | Human |
| Clone: | Z48P3H8*B5 |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Vasorin Antibody, Anti-VASN, Protein slit-like 2 Antibody, Anti-SLITL2, SLITL2 Antibody |
|---|---|
| Product description: | Vasorin is a Type I membrane protein, which is predominantly expressed in vascular smooth muscle cells in a developmentally regulated pattern. The expression level of Vasorin can be down regulated during vessel repair after arterial injury. Vasorin binds to transforming growth factor beta (TGF-ÄÂ?) and attenuates TGF-ÄÂ? signaling in vitro. Vasorin is a potential therapeutic target for vascular fibroproliferative disorders. |
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Immunogen: | Ovalbumin-conjugated synthetic peptide – QSPLHAKPYI |
| Myeloma used: | P3X63Ag8.653 |
| Target background: | Vasorin is a Type I membrane protein, which is predominantly expressed in vascular smooth muscle cells in a developmentally regulated pattern. The expression level of Vasorin can be down regulated during vessel repair after arterial injury. Vasorin binds to transforming growth factor beta (TGF-ÄÂ?) and attenuates TGF-ÄÂ? signaling in vitro. Vasorin is a potential therapeutic target for vascular fibroproliferative disorders. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.